1. Nilotinib Accord 200 mg trde kapsule

Nilotinib Accord 200 mg trde kapsule

Nilotinib

General information

Drug nameNilotinib Accord 200 mg trde kapsule
Medicine nameNilotinib
National drug code3006181
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupChemical Medicinal Product
OriginatorNo
Orphan drugNo

Marketing authorization

Procedure typePotrditev podatkov za CP zdravila (modro okence)
No. and date of decision/certificate1024-11/2026-3, 3. 3. 2026
Authorization validity dateUntil further notice
Marketing end date—
Application type—
Authorization/certificate holderAccord Healthcare S.L.U.

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

LANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01ANTINEOPLASTIC AGENTS
L01EPROTEIN KINASE INHIBITORS
L01EABCR-ABL tyrosine kinase inhibitors
L01EA03nilotinib

Route of administration

Route of administration name
Peroralna uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

The medicinal product is present in wholesale distribution.

Last drug update date:9. 7. 2026
TEST APPLICATION